5 Followers on Owler

Candel Therapeutics

is a Massachusetts-based biotechnology company that develops and commercializes oncolytic viral immunotherapies to treat cancer... Read more

Overview Competitors Funding News & Insights

Candel Therapeutics

is a Massachusetts-based biotechnology company that develops and commercializes oncolytic viral immunotherapies to treat cancer... Read more

President & CEO

Paul Peter Tak

CEO Approval Rating

90/100

1999

NeedhamMassachusetts

PublicNASDAQCADL

Pharmaceuticals & Biotechnology

https://www.candeltx.com

Annual Revenue

$ < 1M

Employees

60

News

Candel Therapeutics received $100M in Post-IPO Equity Funding

Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors

Conference Presentation

Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London

Candel Therapeutics Competitors

1

2

3

4

5

6

7

8

Unlock 5 + competitors

Trending Companies